Cardiac involvement in systemic sclerosis (SSc) is a frequent visceral complication that
considerably affects the prognosis of the disease. The pathophysiologic hallmark is …

Objectives To determine the frequency, associated clinical factors, and prognostic
significance of left ventricular (LV) diastolic dysfunction in systemic sclerosis (SSc). Methods …

Background Myocardial fibrosis has recently been proposed as one of the contributing
factors to the diverse pathogenicity of cardiomyopathy in sickle cell disease. Objective In this …

The incidence of left ventricular (LV) diastolic dysfunction is increased in systemic sclerosis
(SSc), while systolic dysfunction is present in a small percentage of patients. The aim of this …

Background Cardiopulmonary involvement in systemic sclerosis (SSc) is a poor prognostic
factor, due to pulmonary hypertension and right ventricular dysfunction. We assessed the …

Objectives Cardiac involvement is common in systemic sclerosis (SSc) patients. In this study,
we aimed to systematically evaluate the relationship between SSc and left ventricular …

Systemic scleroderma is a disease that is characterized by excessive fibroblastic activity and
collagen deposition in various organs, including the heart. We sought to evaluate the limits …

Background: Systemic sclerosis (SSc) is a connective tissue disease characterised by
vascular changes and immunologically induced fibrosis of the skin and internal organs …

Background: Pulmonary arterial hypertension (PAH) is a well‐known complication of
systemic sclerosis (SSc). Doppler echocardiographic screening for the detection of PAH (by …

Background Heart involvement is frequent although often clinically silent in systemic
sclerosis (SSc) patients. Early identification of cardiac involvement can be improved by …